Health care practitioners need to be fully aware of these products and accompanying considerations if they are to make informed decisions together with their patients (Clinical Diabetes)
Diabetes News
Tag: biosimilar
Answers to commonly asked questions about biosimilar versions of insulin glargine
This briefing sheet is intended to support prescribers by providing answers to
commonly asked questions about the introduction of these medicines (London Medicines Evaluation Network Review)
Evaluating biosimilar medicines
NICE’s position and process for developing guidance and advice for these medicines has been reviewed (National Institute for Health and Care Excellence)
Glycosmedia is also available as an App: